APIs (Active Pharmaceutical Ingredients) are responsible for the pharmaceutical effect of formulated pharmaceuticals (medicines).
What are APIs?
APIs (Active Pharmaceutical Ingredients) are responsible for the pharmaceutical effect of formulated pharmaceuticals (medicines). They are produced using highly technological industrial processes, both during the R&D and commercial production phases.
Europe traditionally has a very strong and important API manufacturing base with a high level of technical competence, employing a range of skilled, highly qualified and experienced staff.
Components of Medications
All drugs are made up of two core components: the API, which is the central ingredient, and the excipient, the substance inside the drug that helps deliver the medication to your system. Excipients are inactive substances, such as mineral oil, and not chemically active
The mission of the European Active Pharmaceutical Ingredients manufacturers is to provide patients and healthcare professionals with top quality pharmaceutical ingredients for their medicines, thus ensuring the availability, affordability and adequate choice of pharmaceuticals that help to promote quality of life.
This mission can only be achieved by leveling the global playing field, by means of an effective Industrial Policy for the European API sector, which helps to improve its competitiveness and high quality standards
In Europe & Beyond
The API market is increasingly a global business integrated in the supply chain of pharmaceuticals, in which APIs constitute the most important components in terms of clinical efficacy and value.
Outlook & Policy
An effective Industrial Policy for the Active Pharmaceutical Ingredients should improve the competitiveness of the EU API industry as well as facilitate its better access to other geographical areas.